Antiviral Clinical Trial for Long Covid-19
Phase 2
90
about 1.3 years
18+
1 site in NY
What this study is about
This trial is testing if two repurposed HIV antivirals can reduce symptom burden in adults with Long Covid compared to placebo. Participants will be randomly assigned to receive antivirals, Truvada (tenofovir disoproxil/emtricitabine), Selzentry, or a placebo taken daily for 90 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take Selzentry
- 3.Take tenofovir disoproxil/emtricitabine
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
emtricitabine, tenofovir disoproxil
oral (Oral Capsule)
Primary: EuroQol 5-Dimension 5-Level (EQ-5D-5L) Visual Analogue Scale
Secondary: Composite Autonomic Symptom Score 31(COMPASS-31), Fatigue Severity Scale (FSS), Fatigue Visual Analogue Scale (F-VAS), General Symptom Questionnaire (GSQ-30), Generalized Anxiety Disorder (GAD-7), Neuro-QoL™ v2.0 Cognitive Function-Short Form, Pain Visual Analogue Scale (P-VAS), Patient Health Questionnaire (PHQ-9)